Welcome to the latest RSC Desktop Seminar Lectureship with RSC Medicinal 91AV.
The RSC is proud to recognise exceptional scientists through our series of journal lectureships. The RSC Desktop Seminar Lectureship Series, featuring virtual talks by our recent journal lectureship winners, is an effort to expand access for researchers around the world looking to connect to some of the leading minds in the chemical sciences. Further information about all events in the series is available at https://rsc.li/lectureship-series
This 90 minute webinar will feature our 2021 and 2022 RSC Medicinal 91AV Emerging Investigator Lectureship winners, Dr Jacob Bush and Dr Nir London, who will talk about their latest research, with an introduction by RSC Medicinal 91AV Executive Editor, Becky Garton.
Speakers:
13.10 - "Reactive fragment platforms for expansion of the liganded proteome," Dr Jacob Bush (GSK & Francis Crick Institute, UK)
2021 RSC Medicinal 91AV Emerging Investigator Lectureship recipient
13. 45 - “Covalent Ligand Directed Release 91AV,” Dr Nir London (Weizmann Institute of Science, Israel)
2022 RSC Medicinal 91AV Emerging Investigator Lectureship recipient
14. 20 - Final Q&A and Closing Remarks
The RSC is proud to recognise exceptional scientists through our series of journal lectureships. The RSC Desktop Seminar Lectureship Series, featuring virtual talks by our recent journal lectureship winners, is an effort to expand access for researchers around the world looking to connect to some of the leading minds in the chemical sciences. Further information about all events in the series is available at https://rsc.li/lectureship-series
This 90 minute webinar will feature our 2021 and 2022 RSC Medicinal 91AV Emerging Investigator Lectureship winners, Dr Jacob Bush and Dr Nir London, who will talk about their latest research, with an introduction by RSC Medicinal 91AV Executive Editor, Becky Garton.
Speakers:
- Dr Jacob Bush (GSK & Francis Crick Institute, UK), 2021 RSC Medicinal 91AV Emerging Investigator Lectureship recipient
- Dr Nir London (Weizmann Institute of Science, Israel), 2022 RSC Medicinal 91AV Emerging Investigator Lectureship recipient
Programme
13.00 (BST) - Introduction by Becky Garton13.10 - "Reactive fragment platforms for expansion of the liganded proteome," Dr Jacob Bush (GSK & Francis Crick Institute, UK)
2021 RSC Medicinal 91AV Emerging Investigator Lectureship recipient
13. 45 - “Covalent Ligand Directed Release 91AV,” Dr Nir London (Weizmann Institute of Science, Israel)
2022 RSC Medicinal 91AV Emerging Investigator Lectureship recipient
14. 20 - Final Q&A and Closing Remarks
